Does OFATUMUMAB Cause Product packaging issue? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Product packaging issue have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.1% of all adverse event reports for OFATUMUMAB.
22
Reports of Product packaging issue with OFATUMUMAB
0.1%
of all OFATUMUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging issue From OFATUMUMAB?
Of the 22 reports, 1 (4.5%) required hospitalization.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which OFATUMUMAB Alternatives Have Lower Product packaging issue Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB